share_log

Craig-Hallum Initiates Coverage On ScPharmaceuticals With Buy Rating, Announces Price Target of $20

Craig-Hallum Initiates Coverage On ScPharmaceuticals With Buy Rating, Announces Price Target of $20

Craig-Hallum以買入評級開始對SCPharmicals進行報道,宣佈目標股價爲20美元
Benzinga ·  2023/09/07 08:48

Craig-Hallum analyst Chase Knickerbocker initiates coverage on scPharmaceuticals (NASDAQ:SCPH) with a Buy rating and announces Price Target of $20.

克雷格-哈勒姆分析師大通·尼克博克在納斯達克(Sequoia PharmPharmticals)(Sequoia PharmPharmticals:SCPH)上啟動了買入評級,並宣佈目標價為20美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論